跳至主要内容
临床试验/ACTRN12614001172695
ACTRN12614001172695已完成2 期

A pilot study on the efficacy and safety of Chinese herbal medicine for children with moderate to severe atopic eczema

RMIT University, Australia0 个研究点目标入组 30 人开始时间: 2014年11月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
6 Years 至 16 Years(—)
性别
All

入选标准

  • I. Diagnosis of the condition:
  • a) History of skin pruritus in the last 12 months plus three or more of the any followings;
  • b) Onset under the age of two ;
  • c) History of flexural involvement;
  • d) History of a generally dry skin ;
  • e) Personal history of other atopic disease such as asthma
  • fe) Visible flexural dermatitis;
  • II. Severity of AE
  • The total score of NESS greater than or equals to 9 (moderate to severe) in baseline measurement;
  • III. Age: from 6 to 16 years old;
  • IV. Completion of informed consent form.

排除标准

  • a) Use of corticosteroids, other immunosuppressives, or any preparation of CHM or other herbal medicines for treatment of AE orally in the past 30 days;
  • b) Diagnosis of scabies, allergic contact dermatitis, seborrhoeic dermatitis or psoriasis;
  • c) Under six years or over 16 years old;
  • d) Severe medical conditions such as cardiovascular, liver or renal dysfunction;
  • e) History of lactose intolerance.

研究者

发起方
RMIT University, Australia

相似试验